Eden Prairie, Minnesota-based Hemosphere announced Tuesday that the company has obtained European market clearance for the HeRO Graft, an alternative to central venous catheters that are used by hemodialysis patients. People suffering from kidney failure require central venous catheters to get hemodialysis treatment, but those catheters have an external opening that can lead to infection […]
Hemosphere Inc., which sells a vein-access device for chronic kidney disease patients, has hired a former St. Jude Medical sales and marketing leader as its new chief executive. Patrick Wethington spent about 10 years with St. Jude before his most recent post, vice president of sales and marketing at Sweden-based Gambro Inc., which also sells […]
After more than 20 years in corporate America, Doris Engibous says she was “big-companied out.” So the medical technology veteran jumped at the opportunity to move from California to Minnesota six years ago to become a first-time CEO for Hemosphere Inc., which has developed a vein-access device for chronic kidney disease patients who need hemodialysis. […]
Hemosphere Inc. has raised more than $9.3 million in equity for its vascular access device that’s used by patients undergoing dialysis, according to a filing with the Securities and Exchange Commission. The company’s HeRo device is designed for use in patients with chronic kidney disease who’ve suffered damage to their veins. The device is implanted […]
